[1] Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012; 380, 2095−128. doi:  10.1016/S0140-6736(12)61728-0
[2] Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet, 2016; 387, 251−72. doi:  10.1016/S0140-6736(15)00551-6
[3] Nguyen-Thanh HT, Benzaquen BS. Screening for subclinical coronary artery disease measuring carotid intima media thickness. Am J Cardiol, 2009; 104, 1383−8. doi:  10.1016/j.amjcard.2009.07.005
[4] Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation, 2007; 115, 459−67. doi:  10.1161/CIRCULATIONAHA.106.628875
[5] Sipila K, Moilanen L, Nieminen T, et al. Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey. Atherosclerosis, 2009; 204, 276−81. doi:  10.1016/j.atherosclerosis.2008.08.029
[6] Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol, 2010; 30, 182−5. doi:  10.1161/ATVBAHA.109.196980
[7] Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis, 2012; 220, 128−33. doi:  10.1016/j.atherosclerosis.2011.06.044
[8] Wang PQ, Wang Y, Zhang GB, et al. Study on the carotid atherosclerotic plaque of patients suffering from ischemic cerebrovascular disease by 64 slices CT. Eur Rev Med Pharmacol Sci, 2015; 19, 3480−5.
[9] Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet, 2005; 365, 1415−28. doi:  10.1016/S0140-6736(05)66378-7
[10] Song QB, Zhao Y, Liu YQ, et al. Sex difference in the prevalence of metabolic syndrome and cardiovascular-related risk factors in urban adults from 33 communities of China: The CHPSNE study. Diab Vasc Dis Res, 2015; 12, 189−98. doi:  10.1177/1479164114562410
[11] Kuschnir MC, Bloch KV, Szklo M, et al. ERICA: prevalence of metabolic syndrome in Brazilian adolescents. Rev Saude Publica, 2016; 50, 11s.
[12] Bonora E, Kiechl S, Willeit J, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care, 2003; 26, 1251−7. doi:  10.2337/diacare.26.4.1251
[13] Yin JH, Song ZY, Shan PF, et al. Age- and gender-specific prevalence of carotid atherosclerosis and its association with metabolic syndrome in Hangzhou, China. Clin Endocrinol (Oxf), 2012; 76, 802−9. doi:  10.1111/j.1365-2265.2011.04198.x
[14] Hassinen M, Komulainen P, Lakka TA, et al. Metabolic syndrome and the progression of carotid intima-media thickness in elderly women. Arch Intern Med, 2006; 166, 444−9. doi:  10.1001/archinte.166.4.444
[15] Zhang YF, Hong J, Zhan WW, et al. Hyperglycaemia after glucose loading is a major predictor of preclinical atherosclerosis in nondiabetic subjects. Clin Endocrinol (Oxf), 2006; 64, 153−7. doi:  10.1111/j.1365-2265.2005.02440.x
[16] Leoncini G, Ratto E, Viazzi F, et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Intern Med, 2005; 257, 454−60. doi:  10.1111/j.1365-2796.2005.01468.x
[17] Ishizaka N, Ishizaka Y, Yamakado M, et al. Association between metabolic syndrome and carotid atherosclerosis in individuals without diabetes based on the oral glucose tolerance test. Atherosclerosis, 2009; 204, 619−23. doi:  10.1016/j.atherosclerosis.2008.10.022
[18] Mattsson N, Ronnemaa T, Juonala M, et al. Arterial structure and function in young adults with the metabolic syndrome: the Cardiovascular Risk in Young Finns Study. Eur Heart J, 2008; 29, 784−91. doi:  10.1093/eurheartj/ehm576
[19] Johnson HM, Douglas PS, Srinivasan SR, et al. Predictors of carotid intima-media thickness progression in young adults: the Bogalusa Heart Study. Stroke, 2007; 38, 900−5. doi:  10.1161/01.STR.0000258003.31194.0a
[20] Ishizaka N, Ishizaka Y, Hashimoto H, et al. Metabolic syndrome may not associate with carotid plaque in subjects with optimal, normal, or high-normal blood pressure. Hypertension, 2006; 48, 411−7. doi:  10.1161/01.HYP.0000233466.24345.2e
[21] Leng XY, Chen XY, Chook P, et al. Association between metabolic syndrome and carotid atherosclerosis: a community-based study in Hong Kong. Metab Syndr Relat Disord, 2013; 11, 109−14. doi:  10.1089/met.2012.0099
[22] Luo TY, Liu XH, Dai TY, et al. Ideal Cardiovascular Health Metrics and Coronary Artery Calcification in Northern Chinese Population: A Cross-sectional Study. Biomed Environ Sci, 2016; 29, 475−83.
[23] Zhou Y, Li Y, Xu L, et al. Asymptomatic polyvascular abnormalities in community (APAC) study in China: objectives, design and baseline characteristics. PLoS One, 2013; 8, e84685. doi:  10.1371/journal.pone.0084685
[24] Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc, 2003; 35, 1381−95. doi:  10.1249/01.MSS.0000078924.61453.FB
[25] Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 2006; 23, 469−80. doi:  10.1111/j.1464-5491.2006.01858.x
[26] Ge S, Xu X, Zhang J, et al. Suboptimal health status as an independent risk factor for type 2 diabetes mellitus in a community-based cohort: the China suboptimal health cohort study. EPMA J, 2019; 10, 65−72.
[27] Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation, 1997; 96, 1432−7. doi:  10.1161/01.CIR.96.5.1432
[28] Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis, 2012; 34, 290-6.
[29] Lorenz MW, Polak JF, Kavousi M, et al. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet, 2012; 379, 2053−62. doi:  10.1016/S0140-6736(12)60441-3
[30] Den Ruijter HM, Peters SA, Anderson TJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. Jama, 2012; 308, 796−803. doi:  10.1001/jama.2012.9630
[31] Kawada T, Andou T, Fukumitsu M. Metabolic syndrome showed significant relationship with carotid atherosclerosis. Heart Vessels, 2016; 31, 664−70. doi:  10.1007/s00380-015-0668-y
[32] Spence JD. Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies. Int J Stroke, 2006; 1, 216−21. doi:  10.1111/j.1747-4949.2006.00068.x
[33] Johnsen SH, Mathiesen EB. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep, 2009; 11, 21−7. doi:  10.1007/s11886-009-0004-1
[34] Despres JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol, 2008; 28, 1039−49. doi:  10.1161/ATVBAHA.107.159228
[35] Yousuf O, Mohanty BD, Martin SS, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol, 2013; 62, 397−408. doi:  10.1016/j.jacc.2013.05.016
[36] Oda E. Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population. Heart Vessels, 2014; 29, 496−503. doi:  10.1007/s00380-013-0386-2
[37] Rundek T, White H, Boden-Albala B, et al. The metabolic syndrome and subclinical carotid atherosclerosis: the Northern Manhattan Study. J Cardiometab Syndr, 2007; 2, 24−9. doi:  10.1111/j.1559-4564.2007.06358.x